SCHEMBL7747223

SCHEMBL7747223

CCOC(=O)/C=C/c1ccc(NC(=O)COC)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.63
RAB9A P51151 1/20 0.60
CA12 O43570 1/20 0.58
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
CA7 P43166 1/20 0.58
CA9 Q16790 1/20 0.58
CA14 Q9ULX7 1/20 0.58
KMT2A Q03164 7/20 0.56
ALDH1A1 P00352 5/20 0.56
MEN1 O00255 3/20 0.56
LMNA P02545 1/20 0.56
PKM P14618 1/20 0.55
HTT P42858 1/20 0.53
HPGD P15428 2/20 0.52
CYP3A4 P08684 1/20 0.52
KDM4E B2RXH2 3/20 0.52
TTR P02766 1/20 0.51
DPP4 P27487 1/20 0.51
TDP1 Q9NUW8 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7747230 1.00 MAPT (0.63) MAPTRAB9ACA12CA1CA2
SCHEMBL7746773 0.87 CA12 (0.63) MAPTRAB9ACA12CA1CA2
SCHEMBL7746772 0.87 CA12 (0.63) MAPTRAB9ACA12CA1CA2
SCHEMBL14358671 0.84 HPGD (0.67) MAPTRAB9AKMT2AALDH1A1HTT
SCHEMBL14358675 0.84 HPGD (0.67) MAPTRAB9AKMT2AALDH1A1HTT
SCHEMBL6984318 0.83 CA12 (0.65) MAPTRAB9ACA12CA1CA2
SCHEMBL6984316 0.83 CA12 (0.65) MAPTRAB9ACA12CA1CA2
SCHEMBL8564390 0.83 HPGD (0.59) MAPTRAB9AKMT2AALDH1A1MEN1
SCHEMBL8564387 0.83 HPGD (0.59) MAPTRAB9AKMT2AALDH1A1MEN1
SCHEMBL27615204 0.82 CA12 (0.56) MAPTRAB9ACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0622361-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO (JP) 2001-10-04 EP disclosed
US-6169095-B1 FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES IN THE EYE, SUCH AS ALLERGY, INFLAMMATION AND PAIN OF THE EYE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
US-5922711-A ANTIALLERGENS, ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES, SHOCK OR ANALGESICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-07-13 US disclosed
EP-0596406-B1 Imidazo (1,2-a) Pyridines as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO (JP) 1998-12-16 EP disclosed
US-5750699-A HALOGENATING OF CORRESPONDING COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-12 US disclosed
US-5708173-A PREPARATION OF SUBSTITUTED QUINOLINE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-13 US disclosed
US-5574042-A ANTAGONIST FOR BRADYKININS AS ANTIALLERGENS, AUTOIMMUNE DISEASES, ANTIINFLAMMATORY AGENTS, SHOCK OR PAIN FUJISAWA PHARMACEUTICAL CO., LTD (JP) 1996-11-12 US disclosed
US-5563162-A CAN BE ADMINISTERD FOR THE TREATMENT OF ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASES, SHOCK OR PAIN IN ANIMALS AND HUMANS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-08 US disclosed
EP-0622361-A1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-02 EP disclosed
EP-0596406-A1 Imidazo (1,2-a) Pyridines as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-05-11 EP disclosed